Related references
Note: Only part of the references are listed.Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
The Role of Notch Signaling in Macrophages during Inflammation and Infection: Implication in Rheumatoid Arthritis?
Esra'a Keewan et al.
CELLS (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
Wen Zhang et al.
CLINICAL IMMUNOLOGY (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction
Sebastien Miranda et al.
PLOS ONE (2019)
TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection
Naoko Iwata-Yoshikawa et al.
JOURNAL OF VIROLOGY (2019)
Comparison of the effect of the antiandrogen apalutamide (ARN-509) versus bicalutamide on the androgen receptor pathway in prostate cancer cell lines
Michael I. Koukourakis et al.
ANTI-CANCER DRUGS (2018)
Global Trends and Prostate Cancer: A Review of Incidence, Detection, and Mortality as Influenced by Race, Ethnicity, and Geographic Location
Harold Evelyn Taitt
AMERICAN JOURNAL OF MENS HEALTH (2018)
TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer
Ken J. Kron et al.
NATURE GENETICS (2017)
Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
Mizuki Yamamoto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
TMPRSS2:ERG fusion gene occurs less frequently in Chinese patients with prostate cancer
Hui Jiang et al.
TUMOR BIOLOGY (2016)
Identification of TMPRSS2 as a Susceptibility Gene for Severe 2009 Pandemic A(H1N1) Influenza and A(H7N9) Influenza
Zhongshan Cheng et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Dual Targeting of the Androgen Receptor and Hypoxia-Inducible Factor 1α Pathways Synergistically Inhibits Castration-Resistant Prostate Cancer Cells
Elena V. Fernandez et al.
MOLECULAR PHARMACOLOGY (2015)
Type II Transmembrane Serine Protease Gene Variants Associate with Breast Cancer
Kaisa Luostari et al.
PLOS ONE (2014)
Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts
Stephanie Bertram et al.
PLOS ONE (2012)
Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val
Veda N. Giri et al.
BJU INTERNATIONAL (2011)
Activation of NF-κB by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4
Jianghua Wang et al.
CANCER RESEARCH (2011)
Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer
Liesel M. FitzGerald et al.
BMC CANCER (2008)
The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma
J. M. Lucas et al.
JOURNAL OF PATHOLOGY (2008)
Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus
Paul B. McCray et al.
JOURNAL OF VIROLOGY (2007)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome
RWK Chiu et al.
CLINICAL CHEMISTRY (2004)